Volume dodolan mangsa ngarep perusahaan: Ultragenyx Corp (RARE)

Logo perusahaan publik Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical (RARE) develops revolutionary therapies for rare pathologies, driving growth within untapped medical niches. The company's expected execution level demonstrates a development trend where the current parameter equals 0.73. The monopoly status of its drugs enables the company to maintain pricing power, while its reliance on external contractors minimizes capital expenditures associated with maintaining proprietary manufacturing plants.

Ultragenyx Pharmaceutical - Pendapatan mangsa ngarep perusahaan RARE (periode 04.07.2022 - 18.11.2026)

Rincian metrik keuangan lan pasar Ultragenyx Pharma (RARE)

- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:RARE Ultragenyx
Produk merek Ultragenyx Pharmaceutical Inc.

To identify fundamental benchmarks in the financial reporting of Ultragenyx Pharmaceutical (RARE), it is critical for investors to track projected revenue, which measures cash flow generation potential by calculating expected demand. By analyzing sales expectations for the company's products, one can confirm the business's resilience, where a patent monopoly in metabolic gene therapy eliminates price competition and guarantees stable revenue growth.

Pesaing langsung

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Twist Bioscience Corp TWST|Prakiraan volume dodolan TXG|Prakiraan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Volume dodolan mangsa ngarep perusahaan|BioLife Solutions Inc (BLFS) - Volume dodolan sing dikarepake perusahaan|wavelifesciences.com - Prakiraan volume dodolan|Maze Therapeutics Corp (MAZE) - Volume dodolan mangsa ngarep perusahaan|SION: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PRME|Prakiraan pendapatan perusahaan Taysha Gene Therapies|Prakiraan pendapatan perusahaan QURE (uniQure)|Prakiraan pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Solid Biosciences SLDB|OCGN - Volume dodolan mangsa ngarep perusahaan|pacb.com - Prakiraan volume dodolan|Benitec (BNTC) - Volume dodolan mangsa ngarep perusahaan|DSGN: Prakiraan volume dodolan|RCKT - Dodolan mangsa ngarep perusahaan|FDMT: Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan LXEO (lexeotx.com)|Prakiraan pendapatan perusahaan Korro Bio Inc. (KRRO)|Prakiraan volume pendapatan perusahaan EDIT|Prakiraan volume dodolan SLN (Silence Therapeutics PLC)|Pendapatan mangsa ngarep perusahaan PRQR|CDXS - Prakiraan pendapatan perusahaan|SGMO (Sangamo Therapeutics) - Prakiraan pendapatan perusahaan|NAUT: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan MGX|DTIL (precisionbiosciences.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan GBIO (Generation Bio Co.)|Prakiraan pendapatan perusahaan Boundless Bio (BOLD)|Exicure - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IMNN (imunon.com)|Dodolan mangsa ngarep perusahaan Phio Pharmaceuticals (PHIO)|MBIO: Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Prakiraan pendapatan perusahaan|APDN - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan BLUE|Prakiraan volume dodolan immunoprecise.com|Prakiraan volume dodolan OMGA|Dodolan mangsa ngarep perusahaan Singular Genomics Corp|Regulus Therapeutics - Volume dodolan mangsa ngarep perusahaan|SYRS (Syros Pharmaceuticals) - Pendapatan sing dikarepake perusahaan|Telesis Bio Inc. - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan TCON (TRACON Pharmaceuticals Inc.)|UBX: Prakiraan volume dodolan